Uncategorised - International Biopharmaceutical Industry

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Subsection - Oncology

Essential DMPK Strategies for IND Success

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Uncategorised

Shionogi and F2G Report Data from Global Phase 3 OASIS Study Evaluating Investigational Oral Olorofim Versus AmBisome® Followed by Standard of Care in Invasive Aspergillosis in Late-Breaking Oral Presentation at IDWeek 2026

Oral olorofim was non-inferior to AmBisome® followed by standard of care (AmBisome®+SOC), with Day 42 all-cause mortality of 23.8% for olorofim versus 24.3% for...

21 October 2026 Uncategorised

Continue Reading →

Company Profile

MicronView

MicronView delivers advanced environmental monitoring solutions, combining innovative instrumentation, automation and software to support critical production env...

3 July 2026 Company Profile | E-M | Uncategorised

Continue Reading →

Uncategorised

CellCarta and Sonic Healthcare Establish Strategic Partnership to Commercialise Companion Diagnostics Through Lab Network

Sonic becomes the first committed commercial laboratory partner in CellCarta's single-site PMA CDx bridging strategy, supporting oncology, autoimmune and other p...

28 May 2026 Uncategorised

Continue Reading →

Uncategorised

SLAS Europe 2025

The Society for Laboratory Automation and Screening leads the global scientific community in bringing laboratory technology users and technology providers together u...

7 April 2025 Uncategorised

Continue Reading →

news

Syngene Acquires its First Manufacturing Facility in the US

Syngene Acquires its First Manufacturing Facility in the US Biologics Drug Substance Facility in Baltimore Expected to Enhance Global Innovator Flexibility ...

11 March 2025 news | Uncategorised

Continue Reading →

Uncategorised

BioTrinity 2025

1-2 April, Convene, 133 Houndsditch, London BioTrinity, now in its 19th year, is OBN's flagship two-day conference for the life sciences industry, designed t...

30 January 2025 Uncategorised

Continue Reading →

Uncategorised

Research & Innovation 2025

Big molecules to big data… thinking BIG to drive innovative research. 10 – 11 March 2025 ELRIG Research & Innovation discusses how emerging biology and cut...

27 January 2025 Uncategorised

Continue Reading →

Uncategorised

The London Biotechnology Show 2025

The London Biotechnology Show is a premier biotechnology event taking place in the United Kingdom to expedite the progress of biotechnology for revolutionising the m...

20 January 2025 Uncategorised

Continue Reading →

Uncategorised

Anglonordic 2025

The 21st Anglonordic Conference will feature up to 90 attending investment firms, on-point panel discussions around European investment and technolog...

20 January 2025 Uncategorised

Continue Reading →

news

GSK says Antibody Drug Succeeds in Testing for Chronic Nasal Condition

Called depemokimab, the company’s treatment reduced the size of nasal polyps in two Phase 3 trials of people with chronic rhinosinusitis. Chronic rhinosinusitis w...

11 December 2024 news | Uncategorised

Continue Reading →